Abstract:BACKGROUND:Previous trials of iron supplementation in infancy did not consider maternal iron supplementation. OBJECTIVE:This study assessed effects of iron supplementation in infancy and/or pregnancy on infant iron status, illnesses, and growth at 9 mo. METHODS:Enrollment occurred from December 2009 to June 2012 in Hebei, China. Infants born to women in a pregnancy iron supplementation trial were randomly assigned 1:1 to iron [∼1 mg Fe/(kg · d) as oral iron proteinsuccynilate] or placebo from 6 wk to 9 mo, excluding infants with cord ferritin <35 μg/L. Study groups were pregnancy placebo/infancy placebo (placebo/placebo), pregnancy placebo/infancy iron (placebo/iron), pregnancy iron/infancy placebo (iron/placebo), and pregnancy iron/infancy iron (iron/iron). The primary outcome was 9-mo iron status: iron deficiency (ID) by cutoff (≥2 abnormal iron measures) or body iron <0 mg/kg and ID + anemia (hemoglobin <110 g/L). Secondary outcomes were doctor visits or hospitalizations and weight or length gain from birth to 9 mo. Statistical analysis by intention to treat and dose-response (between number of iron bottles received and outcome) used logistic regression with concomitant RRs and general linear models, with covariate control as applicable. RESULTS:Of 1482 infants randomly allocated, 1276 had 9-mo data (n = 312-327/group). Iron supplementation in infancy, but not pregnancy, reduced ID risk: RRs (95% CIs) were 0.89 (0.79, 0.998) for placebo/iron compared to placebo/placebo, 0.79 (0.63, 0.98) for placebo/iron compared to iron/placebo, 0.87 (0.77, 0.98) for iron/iron compared to placebo/placebo, and 0.86 (0.77, 0.97) for iron/iron compared to iron/placebo. However, >60% of infants still had ID at 9 mo. Receiving more bottles of iron in infancy was associated with better infant iron status at 9 mo but only among iron-supplemented infants whose mothers were also iron supplemented (i.e., the iron/iron group). There were no group differences in hospitalizations or illnesses and no adverse effects on growth overall or among infants who were iron sufficient at birth. CONCLUSIONS:Iron supplementation in Chinese infants reduced ID at 9 mo without adverse effects on growth or illness. Effects of iron supplementation in pregnancy were observed only when higher amounts of iron were distributed in infancy. This trial was registered at clinicaltrials.gov as NCT00613717.

Complementary Food Choices from 6–18 Mo: Effect on Iron (fe) Status and Inflammation

Age of Complementary Foods Introduction and Risk of Anemia in Children Aged 4–6 years: A Prospective Birth Cohort in China

Effects of Daily Iron Supplementation on Motor Development and Brain Connectivity in Preterm Infants: A Diffusion Magnetic Resonance Study

Low-Dose Iron Supplementation in Infancy Modestly Increases Infant Iron Status at 9 Mo Without Decreasing Growth or Increasing Illness in a Randomized Clinical Trial in Rural China.

Maternal Serum Ferritin Concentration is Positively Associated with Newborn Iron Stores in Women with Low Ferritin Status in Late Pregnancy, ,

Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants

Iron Fortification and Inulin Supplementation in Early Infancy: Evaluating the Impact on Iron Metabolism and Trace Mineral Status in a Piglet Model

Effects of complementary food supplements on incidence of anemia among infants and young children in Zhejiang Province

Effect of Home-Based Complementary Food Fortification on Prevalence of Anemia among Infants and Young Children Aged 6 to 23 Months in Poor Rural Regions of China.

[Iron Status and Effect of Early Iron Supplementation on Sub-Clinical Iron Deficiency in Rural School-Age Children from Mountainous Areas of Beijing].

Anemia and Feeding Practices among Infants in Rural Shaanxi Province in China

Finding Temporary Terms in Prolog Programs

Mixture of Ferric Sodium Ethylenediaminetetraacetate (NaFeEDTA) and Ferrous Sulfate: An Effective Iron Fortificant for Complementary Foods for Young Chinese Children

Nutraceutical Compound Concentrations of Muscadine (Vitis rotundifolia Michx.) Grape Cultivars and Breeding Lines

Iron Fortified Complementary Foods Containing a Mixture of Sodium Iron EDTA with Either Ferrous Fumarate or Ferric Pyrophosphate Reduce Iron Deficiency Anemia in 12- to 36-Month-Old Children in a Malaria Endemic Setting: A Secondary Analysis of a Cluster-Randomized Controlled Trial

The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire

Impact of Feeding High-Iron Rice on Plasma Iron, Hemoglobin and Red Blood Cell Variables of Early-Weaned Piglets

Gut Microbiome Alterations following Postnatal Iron Supplementation Depend on Iron Form and Persist into Adulthood

The Effect of Iron Glycine Chelate on Tissue Mineral Levels, Fecal Mineral Concentration, and Liver Antioxidant Enzyme Activity in Weanling Pigs

Investigation on the Dietary Iron Intake of Infants from Four Month-Old to One Year-Old in Shunyi District of Beijing